Amedisys Inc.
AMED
Market Cap$2.98B
Close$
$96.04
4.6% upside
Current Fair Value
4.6% upsideUndervalued by 4.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.98 Billion |
|---|---|
| Enterprise Value | $3.25 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.3 |
| Beta | 0.0 |
| Outstanding Shares | 32,667,631 |
| Avg 30 Day Volume | 213,293 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -305.53 |
|---|---|
| PEG | 781.8 |
| Price to Sales | 1.35 |
| Price to Book Ratio | 2.87 |
| Enterprise Value to Revenue | 1.45 |
| Enterprise Value to EBIT | 15.94 |
| Enterprise Value to Net Income | -334 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.37 |
Revenue Sources
No data
ESG Score
No data
About Amedisys Inc.
CEO: Paul Kusserow